Enzymes
Enzymes(酶)
Enzymes are very efficient and specific catalyst proteins which react with 1 or few types of substrates in biochemical reactions and are responsible for bringing about almost all of the chemical reactions in living organisms. Enzymes speed up reactions by providing an alternative reaction pathway of lower activation energy. Without enzymes, reactions take place at a rate far too slow for the pace of metabolism which means that they speed up the chemical reactions in living things.
There are 2 types of enzymes, ones that help join specific molecules together to form new molecules & others that help break specific molecules apart into separate molecules. Enzymes play many important roles ouside the cell as well. One of the best examples of this is the digestive system. For instance, it is enzymes in your digestive system that break food down in your digestive system break food down into small molecules that can be absorbed by the body. Some enzymes in your digestive system break down starch, some proteins and others break down fats. The enzymes used to digest our food are extra-cellular since they are located outside our cells & enzymes inside our cells are intra-cellular enzymes. Enzymes are used in ALL chemical reactions in living things; this includes respiration, photosynthesis, movement growth, getting rid of toxic chemicals in the liver and so on. Enzymes are proteins that must have the correct structure to be active. They are very easily affected by heat, pH and heavy metal ions.
Ribonucleoprotein enzyme catalytic activity is located in the protein part but for some the catalytic activity is in the RNA part. A catalyst is any substance which makes a chemical reaction go faster, without itself being changed. A catalyst can be used over and over again in a chemical reaction and does not get used up.
Enzymes lower the amount of activation energy needed by binding to the reactants of the reaction they catalyze, thus speed up the reaction and can process millions of molecules per second. Enzymes are typically large proteins with high molecular weight that permit reactions to go at conditions that the body can tolerate.
Enzyme nomenclature is based on what the enzyme reacts with & how it reacts along with the ending ase.
Enzymes must get over the activation energy hurdle.
Enzymes change how a reaction will proceed which reduces the activation energy and makes it faster. The more we increase the enzyme concentration the faster the reaction rate for non-catalyzed reactions. Enzymes that are catalyzed reactions also increase reaction rate at higher level of concentration but up to a certain point called Vmax which means that the enzyme has reached its maximum point. The reaction is limited by both the concentrations of the enzyme and substrate. Enzymes as catalysts take part in reactions which provide an alternative reaction pathway. Enzymes do not undergo permanent changes and remain unchanged at the end of the reaction. They only change the rate of reaction, not the position of the equilibrium.Enzymes as catalysts are highly selective by only catalysing specific reactions due to the shapes of the enzyme’s molecule.
Enzymes contain a globular protein part called apoenzyme and a non-protein part named cofactor or prosthetic group or metal-ion-activator. Changes in temperature and pH have great influence on the intra- and intermolecular bonds that hold the protein part in their secondary and tertiary structures.
Examples of cofactors are 1. Prosthetic group that are permanently bound to the enzyme. 2. Activator group which are cations (positively charged metal ions) & temporarily bind to the active site of the enzyme. 3.Coenzymes, usually vitamins or made from vitamins which are not permanently bound to the enzyme molecule, but combine with the enzyme-substrate complex temporarily. Enzymes require the presence cofactors before their catalytic activity can be exerted. This entire active complex is referred to as the holoenzyme.
Without enzymes, our guts would take weeks to digest our food, our muscles, nerves and bones would not work properly and so on…
Main Enzyme category groups:
Oxidoreductases:
All enzymes that catalyse oxido-reductions belong in this class. The substrate oxidized is regarded as a hydrogen or electron donor. The classification is based on 'donor:acceptor oxidoreductase'. The common name is 'dehydrogenase', wherever this is possible; as an alternative, 'acceptor reductase' can be used. 'Oxidase' is used only where O2 is an acceptor. Classification is difficult in some cases, because of the lack of specificity towards the acceptor.
Transferases:
Transferases are enzymes that transfer a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme 'donor:acceptor grouptransferase'. The common names are normally formed as 'acceptor grouptransferase' or 'donor grouptransferase'. In many cases, the donor is a cofactor (coenzyme) that carries the group to be transferred. The aminotransferases constitute a special case.
Hydrolases:
These enzymes catalyse the hydrolysis of various bonds. Some of these enzymes pose problems because they have a very wide specificity, and it is not easy to decide if two preparations described by different authors are the same, or if they should be listed under different entries. While the systematic name always includes 'hydrolase', the common name is, in most cases, formed by the name of the substrate with the suffix -ase. It is understood that the name of the substrate with this suffix, and no other indicator, means a hydrolytic enzyme. It should be noted that peptidases have recommended names rather than common names.
Lyases:
Lyases are enzymes that cleave C-C, C-O, C-N and other bonds by means other than by hydrolysis or oxidation. They differ from other enzymes in that two (or more) substrates are involved in one reaction direction, but there is one compound fewer in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring. The systematic name is formed according to 'substrate group-lyase'. In common names, expressions like decarboxylase, aldolase, etc. are used. 'Dehydratase' is used for those enzymes that eliminate water. In cases where the reverse reaction is the more important, or the only one to be demonstrated, 'synthase' may be used in the name.
Ligases:
Ligases are enzymes that catalyse the joining of two molecules with concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. 'Ligase' is often used for the common name, but, in a few cases, 'synthase' or 'carboxylase' is used. 'Synthetase' may be used in place of 'synthase' for enzymes in this class.
- 41701(11)
- Activating Transcription Factor(3)
- Adenylate Kinase(10)
- AHCY(3)
- Aldolase(9)
- Asparaginase(5)
- Aurora Kinase(18)
- Beta Lactamase(3)
- Calcium and Integrin Binding(2)
- Calcium/Calmodulin-Dependent Protein Kinase(4)
- Carbonic Anhydrase(49)
- Casein Kinase(36)
- Cathepsin(52)
- Chitinase(5)
- Creatin Kinases(9)
- Cyclin(7)
- Cyclin-Dependent Kinase(18)
- Cyclophilin(23)
- Deaminase(14)
- Decarboxylase(12)
- Dehydrogenase(96)
- Discoidin Domain Receptor Tyrosine Kinase(2)
- DNA Polymerase(4)
- EGF Receptor(3)
- Endonuclease(6)
- Enolase(10)
- Enterokinase(5)
- Epimerase(3)
- Esterase(15)
- FGF Receptors(12)
- FK506 Binding Protein(10)
- Fructosamine 3 Kinase(2)
- Galactosidase(5)
- Glucosidase(32)
- Gluteradoxin(7)
- Glycogen synthase kinase(2)
- Glycosylase(10)
- Glyoxalase(3)
- Granzyme(7)
- Guanylate Kinase(2)
- Heparanase(3)
- Histone Deacetylase(3)
- Hydratase(10)
- Hydrolase(33)
- Hydroxylase(6)
- Isomerase(26)
- Jun N-terminal Kinase(1)
- Jun Proto-Oncogene(2)
- Kallikrein(26)
- Ligase(4)
- Lipase(14)
- Lipocalin(6)
- Lyase(9)
- LYVE1(3)
- Mitogen-Activated Protein Kinase(16)
- MMP(71)
- Mutase(11)
- Natural Enzymes(4)
- Nuclease(18)
- Nucleotidase(4)
- Nudix Type Motif(11)
- Other Enzymes(63)
- Oxidase(23)
- Oxygenase(12)
- Paraoxonase(3)
- Peptidase(41)
- Peroxiredoxin(10)
- Phosphatase(150)
- Phosphorylase(9)
- PI3-kinase(5)
- Polymerase(13)
- PPARG(2)
- Protease(15)
- Proteasome(55)
- Protein Kinase Akt1/PKB alpha(4)
- Protein Kinase-A(7)
- Protein Kinase-C(3)
- Protein Kinases(86)
- Protein Tyrosine Phosphatase(10)
- Reductase(60)
- Secreted Phospholipase A2(10)
- Serine Threonine Kinase(4)
- Sulfatase(8)
- Synthase(23)
- Synthetase(33)
- TGFBR(3)
- TGM2(3)
- TIE1,TIE2
- TIMP(10)
- TPA(4)
- ransaminase
- Transferase(156)
- Tyrosine Kinase(9)
- Ubiquitin Conjugating Enzyme(39)
- Uromodulin(4)
- VEGF Receptors(14)
- Transaminase(19)
- Hexokinase(6)
- TIE1(6)
Enzymes 相关产品(1726)
- GC62889Cathepsin D and E FRET Substrate acetate纯度: >99.00%
Cathepsin D and E FRET Substrate acetate 为 cathepins D 和 E 的荧光底物 (fluorogenic substrate),而不是 B、H 或 I 的荧光底物,它的裂解发生在 Phe-Phe 酰胺键处。Cathepsin D and E FRET Substrate 是用于组织蛋白酶 D 和组织蛋白酶 E 的常规检测和机制研究的有用工具。(激发波长:328 nm; 发射波长:393 nm)
- GC62892CDC25B-IN-2CAS: 134271-74-2
BIA (TMBIM6 antagonist BIA), a potential TMBIM6 antagonist, is an inhibitor of the interaction between TMBIM6 (Transmembrane B cell lymphoma 2-associated X protein (BAX) inhibitor motif-containing 6) and mTORC2, which ultimately blocks AKT activation and cancer progression.
- GC62909CPT-157633CAS: 888213-72-7纯度: >99.00%
CPT-157633 是一种二氟膦酰基甲基苯丙氨酸衍生物,是 PTP1B 抑制剂。 CPT-157633 可防止酗酒引起的葡萄糖耐受不良。
- GC62943DPM-1001 trihydrochloride纯度: >98.00%
DPM-1001 trihydrochloride 是一种有效的,特异性的,具有口服活性的,且非竞争性的蛋白酪氨酸磷酸酶 (PTP1B) 抑制剂,其 IC50 为 100 nM。DPM-1001 trihydrochloride 是特异性 PTP1B 抑制剂 MSI-1436 (IC50=600 nM) 的类似物。DPM-1001 trihydrochloride 具有抗糖尿病特性。
- GC62948Edaravone D5CAS: 1228765-67-0
Edaravone D5 是 Edaravone 的氘代标记物。Edaravone 是一种有效的自由基清除剂,能够抑制大鼠与 MMP-9 有关的脑出血。
- GC62984Ganoderic acid YCAS: 86377-52-8纯度: >98.00%
Ganoderic acid Y是HMG-CoA还原酶抑制剂和α-葡萄糖苷酶(α-glucosidase)抑制剂,其IC 50 值分别为8.6μM和170μM。
- GC63099NCGC00092410CAS: 442898-34-2纯度: >99.50%
NCGC00092410 是一种有效,选择性和非糖性葡萄糖脑苷脂酶 (glucocerebrosidase, GC) 抑制剂,IC50 值为 31 nM。NCGC00092410 对相关水解酶没有活性。NCGC00092410 是一种 GC 分子伴侣,可提高突变型细胞株中葡萄糖脑苷脂酶的活性和溶酶体定位。NCGC00092410可用于戈谢病的研究。
- GC63132OtaplimastatCAS: 1176758-04-5
Otaplimastat (SP-8203) 是一种基质金属蛋白酶 (MMP) 抑制剂,以竞争方式阻断 NMDA 受体介导的兴奋性毒性。Otaplimastat 还具有抗氧化活性。Otaplimastat 可用于脑缺血损伤的研究。
- GC63327Fenvalerate-d5CAS: 1246815-00-8
Fenvalerate-d5 是 Fenvalerate 的氘代物。Fenvalerate 是一种有效的蛋白磷酸酶 2B (钙调神经磷酸酶;calcineurin) 抑制剂,对 PP2B-Aα 的IC50 为 2-4 nM。Fenvalerate 是拟除虫菊酯杀虫剂和杀螨剂。
- GC63442N-Caffeoyl O-methyltyramineCAS: 189307-47-9
N-Caffeoyl O-methyltyramine is a class of alkaloid isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM.
- GC63463Casein Kinase inhibitor A86CAS: 2079069-01-3纯度: >98.00%
Casein Kinase inhibitor A86 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A86 还抑制 CDK7 (TFIIH) 和 CDK9 (P-TEFb)。Casein Kinase inhibitor A86 可诱导白血病细胞凋亡 (apoptosis),并具有有效的抗白血病活性。
- GC63621DoxycyclineCAS: 564-25-0纯度: >98.00%
Doxycycline(多西环素DOX)是一种四环素衍生物的广谱抗生素,通过干扰细菌核糖体30S亚基A位点上活化的氨基酰基tRNA的结合来抑制蛋白质合成。
- GC63705PTP1B-IN-3 diammoniumCAS: 2702673-78-5纯度: >95.00%
PTP1B-IN-3 diammonium 是有效的,有选择性的 PTP1B 抑制剂,对 PTP1B 和 TCPTP 的 IC50 值均为 120 nM。PTP1B-IN-3 diammonium 具有抗糖尿病和抗癌作用。
- GC63788BN82002 hydrochlorideCAS: 1049740-43-3纯度: >98.00%
BN82002 hydrochloride 是 CDC25 phosphatase 家族的有效,选择性和不可逆的泛抑制剂。 BN82002 hydrochloride抑制 CDC25A,CDC25B2,CDC25B3,CDC25C CDC25A 和 25C-cat 的 IC50 值分别为 2.4、3.9、6.3、5.4 和 4.6 µM。 BN82002 hydrochloride 显示出比 CD45 酪氨酸磷酸酶高约 20 倍的选择性。
- GC63921ABBV-CLS-484CAS: 2489404-97-7
ABBV-CLS-484 is a potent PTPN1 or PTPN2 inhibitor with a sub-nanomolar activity.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC62889 | Cathepsin D and E FRET Substrate acetate | - | >99.00% | |
Cathepsin D and E FRET Substrate acetate 为 cathepins D 和 E 的荧光底物 (fluorogenic substrate),而不是 B、H 或 I 的荧光底物,它的裂解发生在 Phe-Phe 酰胺键处。Cathepsin D and E FRET Substrate 是用于组织蛋白酶 D 和组织蛋白酶 E 的常规检测和机制研究的有用工具。(激发波长:328 nm; 发射波长:393 nm) | ||||
| GC62892 | CDC25B-IN-2 | 134271-74-2 | - | |
BIA (TMBIM6 antagonist BIA), a potential TMBIM6 antagonist, is an inhibitor of the interaction between TMBIM6 (Transmembrane B cell lymphoma 2-associated X protein (BAX) inhibitor motif-containing 6) and mTORC2, which ultimately blocks AKT activation and cancer progression. | ||||
| GC62909 | CPT-157633 | 888213-72-7 | >99.00% | |
CPT-157633 是一种二氟膦酰基甲基苯丙氨酸衍生物,是 PTP1B 抑制剂。 CPT-157633 可防止酗酒引起的葡萄糖耐受不良。 | ||||
| GC62943 | DPM-1001 trihydrochloride | - | >98.00% | |
DPM-1001 trihydrochloride 是一种有效的,特异性的,具有口服活性的,且非竞争性的蛋白酪氨酸磷酸酶 (PTP1B) 抑制剂,其 IC50 为 100 nM。DPM-1001 trihydrochloride 是特异性 PTP1B 抑制剂 MSI-1436 (IC50=600 nM) 的类似物。DPM-1001 trihydrochloride 具有抗糖尿病特性。 | ||||
| GC62948 | Edaravone D5 | 1228765-67-0 | - | |
Edaravone D5 是 Edaravone 的氘代标记物。Edaravone 是一种有效的自由基清除剂,能够抑制大鼠与 MMP-9 有关的脑出血。 | ||||
| GC62984 | Ganoderic acid Y | 86377-52-8 | >98.00% | |
Ganoderic acid Y是HMG-CoA还原酶抑制剂和α-葡萄糖苷酶(α-glucosidase)抑制剂,其IC 50 值分别为8.6μM和170μM。 | ||||
| GC63099 | NCGC00092410 | 442898-34-2 | >99.50% | |
NCGC00092410 是一种有效,选择性和非糖性葡萄糖脑苷脂酶 (glucocerebrosidase, GC) 抑制剂,IC50 值为 31 nM。NCGC00092410 对相关水解酶没有活性。NCGC00092410 是一种 GC 分子伴侣,可提高突变型细胞株中葡萄糖脑苷脂酶的活性和溶酶体定位。NCGC00092410可用于戈谢病的研究。 | ||||
| GC63132 | Otaplimastat | 1176758-04-5 | - | |
Otaplimastat (SP-8203) 是一种基质金属蛋白酶 (MMP) 抑制剂,以竞争方式阻断 NMDA 受体介导的兴奋性毒性。Otaplimastat 还具有抗氧化活性。Otaplimastat 可用于脑缺血损伤的研究。 | ||||
| GC63190 | SHP389 | 2235394-90-6 | >98.00% | |
SHP389 是 SHP2 的变构抑制剂,其对 SHP2 和 p-ERK 的 IC50 值均为 36 nM。 | ||||
| GC63322 | MMP13-IN-3 | 1222173-37-6 | - | |
An inhibitor of MMP-13 | ||||
| GC63327 | Fenvalerate-d5 | 1246815-00-8 | - | |
Fenvalerate-d5 是 Fenvalerate 的氘代物。Fenvalerate 是一种有效的蛋白磷酸酶 2B (钙调神经磷酸酶;calcineurin) 抑制剂,对 PP2B-Aα 的IC50 为 2-4 nM。Fenvalerate 是拟除虫菊酯杀虫剂和杀螨剂。 | ||||
| GC63442 | N-Caffeoyl O-methyltyramine | 189307-47-9 | - | |
N-Caffeoyl O-methyltyramine is a class of alkaloid isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM. | ||||
| GC63451 | Hex | 2004714-32-1 | >99.50% | |
Hex 是烯醇酶 (enolase) 的抑制剂,其对 ENO2 和 ENO1 的 Ki 值分别为 74.4 nM 和 269.4 nM。 | ||||
| GC63463 | Casein Kinase inhibitor A86 | 2079069-01-3 | >98.00% | |
Casein Kinase inhibitor A86 是一种有效且具有口服活性的酪蛋白激酶 1α (CK1α) 抑制剂。Casein Kinase inhibitor A86 还抑制 CDK7 (TFIIH) 和 CDK9 (P-TEFb)。Casein Kinase inhibitor A86 可诱导白血病细胞凋亡 (apoptosis),并具有有效的抗白血病活性。 | ||||
| GC63487 | RMC-4630 | 2172652-48-9 | - | |
RMC-4630 (SHP2-IN-7) 是 一种 SHP2 抑制剂,来自专利 WO2018013597。 | ||||
| GC63621 | Doxycycline | 564-25-0 | >98.00% | |
Doxycycline(多西环素DOX)是一种四环素衍生物的广谱抗生素,通过干扰细菌核糖体30S亚基A位点上活化的氨基酰基tRNA的结合来抑制蛋白质合成。 | ||||
| GC63661 | Aderbasib | 791828-58-5 | - | |
Aderbasb (INCB007839) 是一种有效的、具有口服活性的、靶向特异性的低纳摩尔 ADAM10 和 ADAM17 抑制剂。Aderbasb 表现出强大的抗肿瘤活性,可用于癌症研究,包括弥漫性大 B 细胞非霍奇金淋巴瘤,HER2+ 乳腺癌,胶质瘤等。 | ||||
| GC63705 | PTP1B-IN-3 diammonium | 2702673-78-5 | >95.00% | |
PTP1B-IN-3 diammonium 是有效的,有选择性的 PTP1B 抑制剂,对 PTP1B 和 TCPTP 的 IC50 值均为 120 nM。PTP1B-IN-3 diammonium 具有抗糖尿病和抗癌作用。 | ||||
| GC63788 | BN82002 hydrochloride | 1049740-43-3 | >98.00% | |
BN82002 hydrochloride 是 CDC25 phosphatase 家族的有效,选择性和不可逆的泛抑制剂。 BN82002 hydrochloride抑制 CDC25A,CDC25B2,CDC25B3,CDC25C CDC25A 和 25C-cat 的 IC50 值分别为 2.4、3.9、6.3、5.4 和 4.6 µM。 BN82002 hydrochloride 显示出比 CD45 酪氨酸磷酸酶高约 20 倍的选择性。 | ||||
| GC63856 | Relacatib | 362505-84-8 | - | |
Relacatib (SB-462795) 是一种新的,有效的口服活性的人组织蛋白酶 K, L 和 V (cathepsins K, L, V) 的抑制剂,其Ki 值分别为 41, 68 和 53 pM。Relacatib 原位抑制人破骨细胞内源性组织蛋白酶 K 和人破骨细胞介导的骨吸收,IC50 值分别为 45 nM 和 70 nM。Relacatib 对体外人体组织骨吸收的抑制作用,以及对食蟹猴体内骨吸收有抑制作用。 | ||||
| GC63921 | ABBV-CLS-484 | 2489404-97-7 | - | |
ABBV-CLS-484 is a potent PTPN1 or PTPN2 inhibitor with a sub-nanomolar activity. | ||||
| GC63964 | PR-39 TFA | - | >98.00% | |
PR-39 TFA 是富含脯氨酸和精氨酸的天然抗菌肽,是一种非竞争性,可逆和变构的蛋白酶体 (proteasome) 抑制剂。PR-39 TFA 可逆地结合到蛋白酶体的 α7 亚基上,并通过泛素-蛋白酶体途径阻断 NF-κB 抑制剂 IκBα 的降解。PR-39 TFA 刺激小鼠的血管生成,抑制炎症反应并显着减小心肌梗死面积。 | ||||
| GC64005 | FPFT-2216 | 2367619-87-0 | - | |
FPFT-2216 是一种"分子胶水"化合物,可降解磷酸二酯酶 6D (PDE6D)、锌指转录因子 Ikaros (IKZF1)、Aiolos (IKZF3) 和酪蛋白激酶 1α (CK1α)。FPFT-2216 可用于癌症和炎症疾病的研究。 | ||||
| GC64030 | MY10 | 2204270-73-3 | >98.00% | |
MY10 是一种有效和具有口服活性的的受体蛋白酪氨酸磷酸酶 (RPTPβ/ζ) 抑制剂。MY10 可以减弱了类似暴饮暴食的乙醇消耗和乙醇奖励。 | ||||
